a blood bag partially full of yellow liquid
Convalescent Plasma for COVID-19 Cuts Hospitalizations: Preprint
Unlike studies of antibody-rich transfusions in hospitalized patients, which overall have not found clear benefits, a new randomized trial finds that early convalescent plasma treatment cuts hospitalizations in half.
ABOVE: © ISTOCK.COM, CHANAWIT
Convalescent Plasma for COVID-19 Cuts Hospitalizations: Preprint
Convalescent Plasma for COVID-19 Cuts Hospitalizations: Preprint

Unlike studies of antibody-rich transfusions in hospitalized patients, which overall have not found clear benefits, a new randomized trial finds that early convalescent plasma treatment cuts hospitalizations in half.

Unlike studies of antibody-rich transfusions in hospitalized patients, which overall have not found clear benefits, a new randomized trial finds that early convalescent plasma treatment cuts hospitalizations in half.

ABOVE: © ISTOCK.COM, CHANAWIT

plasma

mice on wheel and ground
Exercise-Associated Protein Boosts Brain Function in Mice
Chloe Tenn | Dec 9, 2021
A study that transfused plasma from active to inactive mice suggests the protein clusterin enhances cognition.
plasma bags hospital
WHO Rejects Convalescent Plasma Treatment for COVID-19
Chloe Tenn | Dec 6, 2021
Current evidence suggests the treatment does not improve survival or reduce the need for ventilation in COVID-19 patients, the World Health Organization says.
Rapid Characterization of the SARS-CoV-2 Immune Response Using the Simple Western Multi-Antigen Serology Assay
The Scientist Creative Services Team | Oct 21, 2020
The Simple Western automated western blotting platform accelerates characterization of the human IgG immune response to COVID-19.
convalescent plasma covid-19 coronavirus pandemic sars-cov-2 antibodies clinical trial NIH emergency use authorization
NIH Halts Outpatient COVID-19 Convalescent Plasma Trial
Marcus A. Banks | Mar 4, 2021
The decision adds to evidence that the benefits of plasma infusions from COVID-19 survivors may be limited, but advocates say the case isn’t closed.
convalescent plasma covid-19 coronavirus pandemic antibodies sars-cov-2 fda emergency use authorization india randomized controlled trial
Indian Study Shows No Survival Benefit of Plasma in COVID-19
Alakananda Dasgupta | Sep 15, 2020
A randomized controlled trial on the use of convalescent plasma therapy to treat coronavirus infections—the first in the world to be completed—yields disappointing results, but some doctors are not discouraged.